Though DDT’s role in hematologic malignancies is unexplored, studies are underway (NCT03918655) to evaluate the prognostic value of MIF during the treatment of FMS-like tyrosine kinase 3 mutated AML [121]. This evidence concerns the gene MIF and acute myeloid leukemia.